리서치 & 클리핑

308080 바이젠셀

4 min read

308080 바이젠셀

기본 정보

  • 섹터: KOSDAQ:일반서비스
  • 시가총액: 1,281억원 (2026-06-30 기준)
  • 첫 등장: — (마커 미등장)
  • 태그: 매크로/바이오헬스 · 세포치료제 · 면역치료 · 항암 · T세포
  • 네이버 금융: 🔗

기업개요

  • 동사는 2013년 설립된 바이오 벤처로 신규 의약품 연구개발 및 면역세포치료제 개발·제조를 함.
  • 2021년 기술성장기업으로 코스닥에 상장하였고, 가톨릭대 의과대학과의 협력 모델을 통해 세포치료제 전문기업으로 성장하고 있음.
  • NK/T세포 림프종 대상 VT-EBV-N이 임상 2상을 완료해 조건부 품목허가를 준비 중이며, 교모세포종 VC-302와 간세포암 VC-420은 전임상 단계 iPSC 유래 NK세포 기반 치료제로 개발하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자전일 종가종가등락률시간외vol색깔smart외연금투투개그외
2026-08-075,3505,400🔴 +0.93%—×0.5🔻 개인-0.1억-0.1+0.0+0.0+0.0+0.1-0.0
2026-08-065,3305,350🔴 +0.38%—×0.8🔻 개인-0.4억-0.4+0.0+0.0+0.0+0.4+0.0
2026-08-055,1405,330🔴 +3.70%—×0.7🔻 개인-0.3억-0.3+0.0+0.0+0.0+0.3+0.0
2026-08-044,8555,140🔴 +5.87%—×0.8🟢 외인+0.1억+0.1+0.0+0.0+0.0-0.1+0.0
2026-08-034,7704,855🔴 +1.78%—×0.5🔻 개인-0.2억-0.2+0.0+0.0+0.0+0.2+0.0
2026-07-314,4304,770🔴 +7.67%—×0.6🟢 외인+1.7억+1.7+0.0+0.0+0.0-1.7+0.0
2026-07-304,5554,430🔵 -2.74%—×0.5🟢 외인+1.0억+1.0+0.0+0.0+0.0-1.0-0.0
2026-07-294,8154,555🔵 -5.40%—×1.2🟢 외인+2.0억+2.0+0.0-0.0+0.0-1.9-0.2
2026-07-285,1904,815🔵 -7.23%—×0.7🔻 개인-0.7억-0.7+0.0+0.0+0.0+0.6+0.1
2026-07-275,2105,190🔵 -0.38%—×0.3🟢 외인+0.1억+0.1+0.0+0.0+0.0-0.1-0.0
2026-07-245,4005,210🔵 -3.52%—×0.5🔻 개인-0.3억-0.3+0.0+0.0+0.0+0.3+0.0
2026-07-235,0905,400🔴 +6.09%—×0.5🟢 외인+1.2억+1.2+0.0-0.0+0.0-1.2+0.0
2026-07-225,0705,090🔴 +0.39%—×0.5🟢 외인+1.2억+1.2+0.0-0.0+0.0-1.2+0.0
2026-07-215,1505,070🔵 -1.55%—×0.5⚫ 그외+0.0억+0.0+0.0+0.0+0.0-0.1+0.0
2026-07-205,5105,150🔵 -6.53%—×0.5🔻 개인-0.2억-0.2+0.0-0.0+0.0+0.2+0.0
2026-07-165,8805,510🔵 -6.29%—×0.6🔻 개인-0.6억-0.6+0.0+0.0+0.0+0.6+0.0
2026-07-155,1905,880🔴 +13.29%—×0.9🟢 외인+1.4억+1.4+0.0-0.0+0.0-1.2-0.1
2026-07-145,3905,190🔵 -3.71%—×0.9⚫ 그외+0.0억+0.0+0.0+0.0+0.0-0.1+0.1
2026-07-135,5205,390🔵 -2.36%—×1.9🔻 개인-3.1억-3.1+0.0-0.0+0.0+3.1+0.0
2026-07-105,5405,520🔵 -0.36%—×0.5🟢 외인+0.5억+0.5+0.0+0.0+0.0-0.6+0.0
2026-07-095,8405,540🔵 -5.14%—×1.3🟢 외인+1.0억+1.0+0.0+0.0+0.0-1.0-0.0
2026-07-085,5105,840🔴 +5.99%—×1.9🔻 개인-8.0억-8.0+0.0-0.1+0.0+8.2-0.1
2026-07-075,5505,510🔵 -0.72%—×0.7🟢 외인+1.1억+1.1+0.0+0.1+0.0-1.2+0.0
2026-07-065,6805,550🔵 -2.29%—×0.7🟢 외인+0.4억+0.4+0.0+0.0+0.0-0.4+0.0
2026-07-035,7405,680🔵 -1.05%—×0.8🟢 외인+1.5억+1.5+0.0-0.1+0.0-1.2-0.2
2026-07-026,1405,740🔵 -6.51%—×0.8🔻 개인-1.1억-1.1+0.0-0.1+0.0+1.2+0.0
2026-07-016,2506,140🔵 -1.76%—×0.8🟢 외인+2.5억+2.4+0.0+0.2+0.0-2.6-0.0
2026-06-306,4206,250🔵 -2.65%—×0.7🔻 개인-2.9억-2.9+0.0+0.0+0.0+2.8+0.0
2026-06-296,0306,420🔴 +6.47%—×0.6🟢 외인+1.2억+1.2+0.0+0.0+0.0-1.4+0.1
2026-06-266,3706,030🔵 -5.34%—×0.9🟢 외인+5.1억+5.1+0.0+0.0+0.0-5.1+0.0
2026-06-256,6106,370🔵 -3.63%—×0.7🟢 외인+1.4억+1.4+0.0+0.0+0.0-1.2-0.2
2026-06-177,5907,630🔴 +0.53%—×0.7🟢 외인+0.8억+0.8+0.0+0.1-0.8-0.1
2026-06-167,8807,590🔵 -3.68%—×0.8🟢 외인+8.1억+8.1+0.0-0.0-8.0-0.0
2026-06-157,9807,880🔵 -1.25%—×0.5🟢 외인+4.8억+4.8+0.0+0.0-4.9+0.1
2026-06-129,2707,980🔵 -13.92%—×0.9🔻 개인-26.1억-26.1+0.0+0.0+25.1+0.9
2026-06-119,3109,270🔵 -0.43%—×0.2🟢 외인+0.8억+0.8+0.0+0.0-0.9+0.1
2026-06-109,8309,310🔵 -5.29%—×0.2🔻 개인-0.5억-0.5+0.0-0.0+0.4+0.2
2026-06-0910,0009,830🔵 -1.70%—×0.2🟢 외인+0.6억+0.6+0.0+0.0-0.5-0.1
2026-06-089,50010,000🔴 +5.26%—×0.5🔻 개인-1.6억-1.6+0.0+0.0+1.3+0.3
2026-06-059,7809,500🔵 -2.86%—×0.2🔻 개인-1.9억-1.9+0.0+0.0+1.9+0.0
2026-06-0410,0009,780🔵 -2.20%—×0.3🔻 개인-1.0억-1.0+0.0+0.0+0.9+0.1
2026-06-0212,08010,000🔵 -17.22%—×0.5🔻 개인-1.4억-1.4+0.0+0.0+1.4-0.0
2026-06-0113,59012,080🔵 -11.11%—×0.6🔻 개인-4.8억-4.8+0.0+0.0+5.0-0.2
2026-05-2913,18013,590🔴 +3.11%—×0.8🔻 개인+1.2억+1.2+0.0+0.0+1.8-3.1

일자별 사유 (최신 위)

2026-07-15

  • 사유: —
  • 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +166억)
  • 매크로 원인: HLB 리보세라닙 FDA 제조 리스크 해소 기대에 그룹주 무더기 상한가, 미프진 허가 검토·항암신약 모멘텀 가세 (보통)

백링크